hereditary cancer
Synergy Oncology to Develop Tumor Profiling Test Using Sophia Genetics DDM Platform
Synergy will incorporate Sophia DDM to launch Totality, a tumor molecular profiling assay to help physicians match variants to therapies and clinical trials.
Researchers are advancing a multiomic method they hope can improve care for patients who have inherited a dramatic risk of developing cancer.
The company, infamous and long derided in the genetic testing community for refusing to share BRCA1/2 variants, has decided to change its stance as part of a "strategic transformation."
Genome Medical, Hereditary Neuropathy Foundation Partner for Charcot-Marie-Tooth Disease Testing
The CMT Genie Project aims to provide faster and more equitable access to genetic testing for the CMT community via virtual services.
African American Prostate Cancer Patients Get More VUS, Fewer Actionable Results, Studies Show
Research presented at ASCO's annual meeting underscores the need for more cancer susceptibility studies in diverse populations, experts say.